Cresci and Bach Moderate at Hypertrophic Cardiomyopathy Society 2023 Scientific Sessions (Links to an external site)
Drs. Sharon Cresci and Richard Bach of the Washington University School of Medicine Hypertrophic Cardiomyopathy Center acted as moderators at the 2023 Hypertrophy Cardiomyopathy Society (HCMS) Scientific Sessions in Cleveland, Ohio.
Cresci receives NIH/National Heart, Lung and Blood Institute Award (Links to an external site)
Sharon Cresci, MD, Associate Professor of Medicine and Genetics in the Cardiovascular Division and Associate Director of the WashU Barnes-Jewish Hospital Hypertrophic Cardiomyopathy Center, recently received a five-year R01 grant from the National Institutes of Health/National Heart, Lung and Blood Institute.
NEW DRUG, POSITIVE RESULTS FOR HYPERTROPHIC CARDIOMYOPATHY (Links to an external site)
An estimated 1 million people in the U.S. have hypertrophic cardiomyopathy—a heart condition also known as HCM—and many don’t know they have the condition until it’s too late. A genetic disease, HCM often goes undetected until someone in the family experiences symptoms, which can range from irregular heart rhythms and stroke to heart failure and death in people of any age. And HCM is the most common cause of sudden cardiac death in young people.
Genetic testing can identify immediate family at risk of HCM (Links to an external site)
As an inherited disease, HCM can run in families—and it can develop at any age. In many instances, HCM is undiagnosed until a significant heart problem occurs. When that happens, genetic testing for the patient and the immediate family can help to clarify the cause of symptoms and offer care options for others in the family who may be at risk. Screening often includes an echocardiogram and genetic testing.
Cresci spearheads precision medicine statement for heart failure (Links to an external site)
Sharon Cresci, MD, an associate professor of medicine and of genetics in the Cardiovascular Division at Washington University School of Medicine in St. Louis, led a committee that developed the American Heart Association’s (AHA) scientific statement on the potential for precision medicine to improve treatment for patients with heart failure.
AHA: Precision Medicine Could Improve Heart Failure Treatment (Links to an external site)
A guide to a custom-tailored era of heart failure treatment (Links to an external site)
Emerging practice of precision medicine could one day improve care for many heart failure patients (Links to an external site)
Quitting smoking after heart attack gives quick boost to mental health, quality of life (Links to an external site)
“Even in people who smoked and had a heart attack, we see fairly rapid improvements in important measures of health and quality of life when they quit smoking after their heart attacks, compared with people who continue smoking,” said senior author Sharon Cresci, MD, assistant professor of medicine.
Study shows race a factor in mortality in heart attack patients on anti-clotting drug (Links to an external site)
“The research is provocative,” said the study’s first author, cardiologist Sharon Cresci, MD, assistant professor of medicine and of genetics. “Knowing about potential genetic differences based on race can help physicians tailor drugs to patients based on their genetic makeup.”
WU researchers find genetic link between coronary artery disease and patients with diabetes (Links to an external site)
“[It’s] something that we see very commonly,” said Dr. Sharon Cresci, assistant professor of medicine and one of the authors of the research paper. “It’s a more high-risk patient population that we’re aware of and would like to be able to have better ways of treating.”